You are here

Novel Micro-Implant to Measure Intracardiac Pressure in Congenital Heart Patients

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44HL110521-04
Agency Tracking Number: R44HL110521
Amount: $2,961,655.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: NHLBI
Solicitation Number: HL14-012
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
YPSILANTI, MI 48198-7812
United States
DUNS: 836116822
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (734) 547-9896
Business Contact
Phone: (734) 660-1490
Research Institution

DESCRIPTION (provided by applicant): PROJECT SUMMARY Congenital heart disease patients with functional single ventricle (FSV) anatomy ultimately require a Fontan operation for long term survival. The goal of the Fontan operation is to re-route systemic venous blood to the pulmonary circulation without passing through an intervening ventricular chamber. As a result, blood flow to the lungs is almost entirely a passive, non-pulsatile process. Although morbidity and mortality associated with the Fontan procedure has improved considerably over the last decade, there are still many patients who develop complications and eventual Fontan failure for reasons we do not yet entirely understand. The pressure in the Fontan pathway is arguably the single measurement thatmost closely predicts the overall health of the palliated circulation. This measurement reflects the general condition of all the cardiac and vascular structures that lie between the branch pulmonary arteries and the systemic single ventricle. Unfor

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government